Long-term costs and survival of prostate cancer: a population-based study.
Valentin BrodszkyPéter VargaJudit Gimesi-OrszághPetra Fadgyas-FreylerImre BonczPeter NyiradyPéter RieszPetra BajiMárta PéntekFanni RenczLászló GulácsiPublished in: International urology and nephrology (2017)
To our knowledge, this study applied the longest time-window in reporting population-based incidence costs in Europe. We found that not only RP patients lived longer but they had significantly lower total long-term costs than nRP patients. Therefore, radical prostatectomy is a cost-effective strategy in prostate cancer.